Table 14 Physician awareness of therapies in development for treating NASH
(a) PCPs n = 152 | Specialists n = 150 | P | |
|---|---|---|---|
Aware of any drug in development | 54 (36) | 91 (61) | <0.001 |
Obeticholic acid (OCA) | 18 (12) | 72 (48) | <0.001 |
Aramchol | 7 (5) | 22 (15) | 0.002 |
GR-MD-02 | 5 (3) | 13 (9) | 0.028 |
Simtuzumab | 9 (6) | 31 (21) | <0.001 |
GFT505 | 4 (3) | 10 (7) | 0.056 |
Proscysbi | 1 (1) | 10 (7) | 0.004 |
Emricasan | 1 (1) | 8 (5) | 0.016 |
GCS-100 | 1 (1) | 2 (1) | 0.374 |
MN-001 | 1 (1) | 5 (3) | 0.090 |
LUM001 | 2 (1) | 3 (2) | 0.312 |